SUBSCRIBE
SUBSCRIBE
News   Business

PDL BioPharma, Inc. CEO Stepping Down

August 21, 2007 | 
1 min read
FREMONT, Calif. (AP) -- PDL BioPharma Inc. said Chief Executive Mark McDade will resign by the end of 2007 and that an internal investigation found no credible evidence of improper personal conduct or breach of fiduciary duty.
People Regulatory
MORE ON THIS TOPIC
Red round circle with a pause button or icon against yellow background.
Gene therapy
Liver Toxicities Force Pause on Two Dose Groups of UniQure’s Mid-Stage Fabry Study
February 9, 2026
 · 
1 min read
 · 
Tristan Manalac
Magnifying glass focusing on number 2026 with target icon on yellow background. Concept for new year focus, business goals, trends, planning, strategy, vision, success, and future opportunities.
Opinion
2025 Reshaped the FDA. What Will 2026 Hold?
February 9, 2026
 · 
6 min read
 · 
Claire Davies
Digital compass. Business strategic explorer, Vision crisis, Mission path, Agency creative, Digital strategy, Market decision, Achievement strategy, Financial stock, Company vision concepts
Policy
FDA Policy Tracker 2026: Priority Vouchers Questioned, PRVs Return
February 9, 2026
 · 
5 min read
 · 
Heather McKenzie
Business meeting idea and planning with strategy as a corporate concept with a mechanical wheel bridge as diverse multiracial businesspeople joining together as a symbol for people diversity and success with 3D render elements.
Earnings
Biogen’s ‘Bridge To Growth’ Cuts Through a Stacked Phase 3 Pipeline
February 6, 2026
 · 
2 min read
 · 
Annalee Armstrong